Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma

Publication Date

2025

Content Type

article

PubMed ID:

40601845

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS